Why was the FDA's VRBPAC meeting for selecting flu vaccine strains canceled?

The FDA did not provide an explanation for the cancellation of the VRBPAC meeting.

How might the cancellation of the FDA meeting affect flu vaccine production for the upcoming season?

The cancellation could delay vaccine production, as manufacturers rely on the meeting to determine which strains to include in the vaccines. This delay might impact the availability of vaccines at the start of the flu season.

What is the current situation with the flu season in the U.S., and how does it relate to vaccine effectiveness?

The current flu season is severe, with record hospitalizations. Early data suggests that this season's flu vaccine may not be well-matched to some circulating strains, particularly H3N2, which could affect vaccine effectiveness.

Is there any uncertainty regarding U.S. participation in international flu strain selection processes?

Yes, there is uncertainty about U.S. participation in the WHO's flu strain selection meeting due to past executive orders, though the CDC has been involved in some international reporting.

4 sources·Health

FDA Canceled Crucial Meeting on Flu Vaccine Strains Amid Severe Flu Season

The FDA's VRBPAC meeting to select flu vaccine strains for the upcoming season has been canceled, raising concerns about vaccine readiness.

25%

75%

The distribution of story sources: left-leaning (blue), center (light gray), and right-leaning (red).

Reliable

The underlying sources consistently report facts with minimal bias, demonstrating high-quality journalism and accuracy.

Balanced

The underlying sources are either a balanced mix of left and right or primarily centrist.

The canceled meeting comes as Robert F. Kennedy Jr., who now leads HHS, makes early moves that could affect vaccination uptake and policy in the U.S.
FDA cancels vaccine advisory meeting for choosing flu strains for next season's shots
CNBC·22d
Reliable
This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
·
Center
This outlet is balanced or reflects centrist views.
The cancelation comes as the United States is in the midst of a particularly severe flu season.
FDA cancels meeting to select flu strains for next season's shots
NBC News·22d
Reliable
This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
·
Center
This outlet is balanced or reflects centrist views.
The cancellation is just the latest federal vaccine meeting to be disrupted.
FDA cancels meeting to update next season's flu vaccines
CBS News·22d
Reliable
This source consistently reports facts with minimal bias, demonstrating high-quality journalism and accuracy.
·
Center
This outlet is balanced or reflects centrist views.

Feb 27th, 2025, 12:41 AM ET

Summary

A summary of the key points of this story verified across multiple sources.

The FDA's annual Vaccines and Related Biological Products Advisory Committee meeting for March, crucial for selecting flu vaccine strains, has been unexpectedly canceled, sparking concerns about the impact on vaccine manufacturing. The cancellation comes amid a severe flu season, leading to record hospitalizations and deaths. With no explanation provided for the cancellation, uncertainties loom over how manufacturers will proceed. Simultaneously, the CDC is dealing with its own postponed meetings. The current HHS leadership raises further worries regarding future vaccine policies.

Perspectives

Compare opinions on this story from liberal (Left), conservative (Right) or center-leaning news organizations.

The FDA has canceled an important advisory meeting that typically selects flu vaccine strains for the upcoming season, leaving guidance for manufacturers uncertain.
The cancellation comes amidst a severe flu season, raising concerns over the availability and effectiveness of next year’s flu vaccines for the public.
The new leadership at HHS, including Robert F. Kennedy Jr., an anti-vaccine advocate, adds further apprehension about the future of vaccine policy in the U.S.

FAQs

A list of follow-up questions readers often ask about this story.